Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Young

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|March 18, 2008
Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient dataJim Young, An De Sutter, Dan Merenstein, et al.
Canadian Liver Journal|July 18, 2025
Progress Toward Hepatitis C Virus Elimination among People Living with HIV-Hepatitis C Virus Coinfection in CanadaMariam Z El Sheikh, Jim Young, Dimitra Panagiotoglou, et al.
Archives of Internal Medicine|October 15, 2008
Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary careMatthias Briel, Philipp Schuetz, Beat Mueller, et al.
HIV Clinical Trials|June 21, 2014
Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backboneQing Wang, Jim Young, Enos Bernasconi, et al.
AIDS (London, England)|July 29, 2004
Is unsafe sexual behaviour increasing among HIV-infected individuals?Tracy R Glass, Jim Young, Pietro L Vernazza, et al.
Antiviral Therapy|March 9, 2005
Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort studyJim Young, Martin Rickenbach, Rainer Weber, et al.
BMC Infectious Diseases|September 23, 2015
Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort StudyJim Young, Martin Rickenbach, Alexandra Calmy, et al.
Antiviral Therapy|September 13, 2005
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort studyJim Young, Rainer Weber, Martin Rickenbach, et al.
Antiviral Therapy|October 9, 2009
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIVJim Young, Heiner C Bucher, Huldrych F Guenthard, et al.
Antiviral Therapy|April 23, 2013
The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort StudyQing Wang, Jim Young, Enos Bernasconi, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|March 18, 2008
Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient dataJim Young, An De Sutter, Dan Merenstein, et al.
Canadian Liver Journal|July 18, 2025
Progress Toward Hepatitis C Virus Elimination among People Living with HIV-Hepatitis C Virus Coinfection in CanadaMariam Z El Sheikh, Jim Young, Dimitra Panagiotoglou, et al.
Archives of Internal Medicine|October 15, 2008
Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary careMatthias Briel, Philipp Schuetz, Beat Mueller, et al.
HIV Clinical Trials|June 21, 2014
Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backboneQing Wang, Jim Young, Enos Bernasconi, et al.
AIDS (London, England)|July 29, 2004
Is unsafe sexual behaviour increasing among HIV-infected individuals?Tracy R Glass, Jim Young, Pietro L Vernazza, et al.
Antiviral Therapy|March 9, 2005
Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort studyJim Young, Martin Rickenbach, Rainer Weber, et al.
BMC Infectious Diseases|September 23, 2015
Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort StudyJim Young, Martin Rickenbach, Alexandra Calmy, et al.
Antiviral Therapy|September 13, 2005
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort studyJim Young, Rainer Weber, Martin Rickenbach, et al.
Antiviral Therapy|October 9, 2009
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIVJim Young, Heiner C Bucher, Huldrych F Guenthard, et al.
Antiviral Therapy|April 23, 2013
The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort StudyQing Wang, Jim Young, Enos Bernasconi, et al.
Pageof 8